Clinic
Mallory Community Health
Mallory Community Health was paid $2.11M by Medicaid between Jan 2018 and Dec 2024, across 86 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 64% of everything it billed.
33Billing provider infoMALLORY COMMUNITY HEALTH
LEXINGTON, MS 39095
LEXINGTON, MS 39095
33aNPI1740624881assigned 04/19/2013
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$2.11M
24GClaims85,374
24DCodes billed86
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Mississippi
Rank by total paid#8 of 189
Median peer was paid$110K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,340 | $183K | |
| 2019 | 7,713 | $325K | |
| 2020 | 5,425 | $288K | |
| 2021 | 8,898 | $447K | |
| 2022 | 23,926 | $327K | |
| 2023 | 22,550 | $306K | |
| 2024incomplete | 12,522 | $235K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 64% | 12,063 | 10,078 | $1.36M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 8.4% | 1,451 | 1,215 | $178K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.4% | 1,330 | 1,197 | $156K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.9% | 656 | 593 | $83K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.3% | 608 | 540 | $70K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.7% | 443 | 422 | $58K |
| D0999 | Unspecified diagnostic procedure, by report | 2.3% | 324 | 301 | $49K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.8% | 328 | 284 | $39K |
| D0140 | Limited oral evaluation - problem focused | 1.4% | 724 | 590 | $31K |
| D1206 | Topical application of fluoride varnish | <1% | 1,483 | 1,319 | $14K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 581 | 516 | $13K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 103 | 98 | $12K |
74 more codes
| D1120 | Dental cleaning, child | <1% | 1,127 | $12K |
| D0120 | Dental checkup, returning patient | <1% | 206 | $6K |
| 99384 | <1% | 43 | $5K | |
| 90649 | <1% | 189 | $5K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 60 | $4K |
| 99205 | Prolong outpt/office vis | <1% | 54 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 29 | $3K |
| 83655 | <1% | 1,355 | $3K | |
| D0330 | Panoramic radiographic image | <1% | 101 | $3K |
| 0002A | <1% | 38 | $789.14 | |
| D0274 | Bitewings - four radiographic images | <1% | 38 | $673.13 |
| 0001A | <1% | 40 | $430.44 | |
| 99441 | <1% | 17 | $374.74 | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 12 | $361.70 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 122 | $273.78 |
| 0071A | <1% | 21 | $179.35 | |
| 85018 | <1% | 2,553 | $155.32 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 42 | $140.11 |
| D0272 | Bitewings - two radiographic images | <1% | 27 | $101.50 |
| 90715 | <1% | 205 | $96.17 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 846 | $46.18 |
| 90677 | <1% | 161 | $0.44 | |
| 90723 | <1% | 412 | $0.27 | |
| 90680 | <1% | 326 | $0.26 | |
| 90633 | <1% | 454 | $0.26 | |
| 90716 | 0% | 322 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 381 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 3,309 | $0.00 |
| 90732 | 0% | 27 | $0.00 | |
| 3079F | 0% | 523 | $0.00 | |
| 3008F | 0% | 6,020 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 350 | $0.00 |
| 3074F | 0% | 4,885 | $0.00 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 103 | $0.00 |
| 92551 | 0% | 3,335 | $0.00 | |
| 85027 | 0% | 44 | $0.00 | |
| 90620 | 0% | 47 | $0.00 | |
| 99000 | 0% | 1,448 | $0.00 | |
| 1125F | 0% | 362 | $0.00 | |
| 1126F | 0% | 4,344 | $0.00 | |
| 90651 | 0% | 333 | $0.00 | |
| 90688 | 0% | 178 | $0.00 | |
| 3075F | 0% | 27 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 17 | $0.00 |
| 90696 | 0% | 41 | $0.00 | |
| 1000F | 0% | 570 | $0.00 | |
| 90697 | 0% | 52 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 319 | $0.00 |
| D0603 | 0% | 233 | $0.00 | |
| 97802 | 0% | 1,337 | $0.00 | |
| 90686 | 0% | 75 | $0.00 | |
| 90647 | 0% | 28 | $0.00 | |
| D1330 | 0% | 71 | $0.00 | |
| 96150 | 0% | 85 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 49 | $0.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 18 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 12 | $0.00 |
| 36416 | 0% | 14 | $0.00 | |
| 99173 | 0% | 3,865 | $0.00 | |
| 1160F | 0% | 6,575 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 1,468 | $0.00 |
| 90670 | 0% | 697 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 910 | $0.00 |
| 3078F | 0% | 4,357 | $0.00 | |
| 90648 | 0% | 818 | $0.00 | |
| 3725F | 0% | 1,526 | $0.00 | |
| 90707 | 0% | 292 | $0.00 | |
| 1159F | 0% | 6,390 | $0.00 | |
| 90734 | 0% | 366 | $0.00 | |
| 81002 | 0% | 265 | $0.00 | |
| 90658 | 0% | 165 | $0.00 | |
| 80061 | Lipid panel | 0% | 12 | $0.00 |
| 81025 | 0% | 120 | $0.00 | |
| 90700 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAPMAN, CLYDE (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Mallory Community Health | Canton, MS | $1.52M |
| Mallory Community Health | Lexington, MS | $1.28M |
| Mallory Community Health | Greenwood, MS | $619K |
| Mallory Community Health | Tchula, MS | $367K |
| Mallory Community Health | Durant, MS | $293K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.